Autolus Therapeutics (AUTL)
NASDAQ: AUTL
· Real-Time Price · USD
1.73
-0.12 (-6.49%)
At close: Aug 15, 2025, 3:59 PM
1.76
1.73%
After-hours: Aug 15, 2025, 07:55 PM EDT
Autolus Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 9.01M | 10.12M | 11.87M | 12.27M | 12.27M | 3.47M | 5.52M | 7.49M | 7.49M | 6.36M | 3.36M | 1.23M | 2.73M | 2.83M | 1.14M | 1.15M | -69K |
Cost of Revenue | 20.07M | 3.92M | 5.7M | 5.86M | 5.47M | 5.57M | 31.21M | 68.46M | 68.86M | 69.03M | 81.25M | 46.07M | 46.39M | 45.99M | 39.9M | 71M | 100.08M |
Gross Profit | -24.52M | -7.27M | 6.17M | 6.41M | 6.8M | -2.1M | -25.68M | -60.97M | -61.38M | -62.67M | -77.89M | -44.84M | -43.66M | -43.15M | -38.76M | -69.85M | -100.15M |
Operating Income | -267.91M | -241.43M | -206.45M | -186.8M | -171.85M | -168.2M | -155.41M | -154.25M | -158M | -163.78M | -183.29M | -176.57M | -166.57M | -164.21M | -163.94M | -166.29M | -168.11M |
Interest Income | 31.56M | 32.36M | 27.92M | 23.25M | 16.99M | 13.51M | 11.92M | 8.44M | 5.13M | 1.71M | 431K | 294K | 247K | 263K | 150K | 159K | 117K |
Pretax Income | -234.37M | -219.13M | -257.8M | -226.52M | -217.32M | -208.4M | -175.66M | -173.79M | -174.3M | -173.21M | -189.23M | -179.69M | -169.68M | -165.99M | -166.34M | -172.14M | -171.68M |
Net Income | -238.13M | -220.66M | -270.23M | -233.98M | -221.26M | -208.38M | -158.16M | -155.08M | -151.59M | -148.84M | -163.55M | -154.78M | -145.89M | -142.1M | -143.29M | -146.62M | -145.49M |
Selling & General & Admin | 112.44M | 99.28M | 79.56M | 62.84M | 52.06M | 44.97M | 38.43M | 36.05M | 33.2M | 31.9M | 32.08M | 32.15M | 31.11M | 31.86M | 33.28M | 34.82M | 36.1M |
Research & Development | 134.5M | 138.44M | 132.76M | 129.68M | 129.81M | 130.48M | 137.51M | 137.9M | 139.37M | 141.99M | 149.44M | 144.1M | 138.02M | 134.79M | 133.88M | 135.13M | 134.33M |
Other Expenses | n/a | n/a | n/a | n/a | 482K | 1.26M | 7.52M | 3.78M | 1.96M | 1.01M | -5.32M | -632K | -1.15M | -146K | -1.21M | -4.67M | -2.29M |
Operating Expenses | 246.94M | 237.72M | 212.32M | 192.52M | 181.87M | 175.45M | 175.94M | 173.95M | 172.57M | 173.73M | 182M | 176.49M | 169.24M | 166.92M | 166.38M | 168.98M | 169.59M |
Interest Expense | 31M | 40.13M | 70.26M | 64.58M | 59.43M | 45.07M | 18.4M | 15.23M | 12.02M | 8.91M | 6.55M | 4.71M | 2.9M | 1.1M | n/a | n/a | 47K |
Selling & Marketing Expenses | n/a | -1.81M | -3.58M | -3.58M | -3.58M | -1.77M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 276.28M | 250.91M | 216.13M | 196.1M | 185.45M | 177.23M | 175.94M | 173.95M | 172.57M | 173.73M | 182M | 176.49M | 169.24M | 166.92M | 166.38M | 168.98M | 169.59M |
Income Tax Expense | 3.76M | 1.53M | 12.43M | 7.46M | 3.94M | -19K | -17.5M | -18.71M | -22.71M | -24.37M | -25.68M | -24.91M | -23.79M | -23.89M | -23.05M | -25.53M | -26.19M |
Shares Outstanding (Basic) | 266.13M | 266.13M | 266.08M | 266.03M | 222.17M | 174.03M | 173.98M | 173.86M | 173.83M | 117.18M | 90.99M | 90.93M | 90.91M | 72.9M | 72.9M | 70.83M | 62.45M |
Shares Outstanding (Diluted) | 266.13M | 266.13M | 266.08M | 266.03M | 222.17M | 174.03M | 173.98M | 173.86M | 173.83M | 117.18M | 91.24M | 90.93M | 90.91M | 72.9M | 72.9M | 70.83M | 62.45M |
EPS (Basic) | -0.9 | -0.88 | -1.21 | -1.16 | -1.2 | -1.19 | -0.98 | -1.19 | -1.39 | -1.57 | -1.91 | -1.91 | -1.92 | -2.04 | -2.16 | -2.41 | -2.56 |
EPS (Diluted) | -0.9 | -0.88 | -1.21 | -1.16 | -1.2 | -1.19 | -0.98 | -1.19 | -1.39 | -1.57 | -1.91 | -1.91 | -1.92 | -2.04 | -2.16 | -2.41 | -2.56 |
EBITDA | -235.74M | -202.13M | -180.13M | -155.08M | -147.91M | -149.76M | -143.75M | -144.64M | -151.46M | -156.81M | -175.42M | -167.06M | -158.54M | -157.04M | -157.3M | -161.61M | -162.08M |
EBIT | -234.21M | -209.84M | -187.54M | -161.93M | -154.38M | -155.87M | -149.8M | -151.09M | -158.32M | -164.3M | -183.29M | -175.6M | -167.41M | -165.5M | -165.23M | -168.56M | -168.05M |
Depreciation & Amortization | 8.19M | 7.72M | 7.41M | 6.86M | 6.47M | 6.57M | 6.5M | 6.91M | 7.32M | 7.49M | 7.97M | 8.63M | 8.95M | 8.55M | 8.02M | 7.04M | 6.06M |